Department of Veterans Affairs Awarded a Contract to PROGENICS PHARMACEUTICALS INC for $1,181,225.28

Q: Where is PROGENICS PHARMACEUTICALS INC located?

331 TREBLE COVE ROAD NORTH BILLERICA MASSACHUSETTS UNITED STATES

Signed on

2/28/2026, 12:00 AM

PROGENICS PHARMACEUTICALS INC Government Contract #36C25026N0354

PROGENICS PHARMACEUTICALS INC was awarded a contract with the United States Government for $1,181,225.28. The contract was awarded by the agency office 250-NETWORK CONTRACT OFFICE 10 (36C250), which is a division with the Department of Veterans Affairs within the Department of Veterans Affairs.

Summary of Award

The recipient of the contract is Progenics Pharmaceuticals Inc, a small U.S.-owned business in North Billerica, Massachusetts, specializing in pharmaceutical preparation manufacturing. The contract, funded by the Department of Veterans Affairs, is for the drug PyLarify 2026 at a total value of $1,181,225.28. The transaction on February 28, 2026, shows the award amount being processed.

Contract Details

Contract ID36C25026N0354

Contract TypeC

Total Obligation$1,181,225.28

Exercised Options$1,181,225.28

Base Amount + Options$1,181,225.28

Date Signed2026-02-28

Contract DescriptionPYLARIFY 2026 - KENT CBOC

Start Date2026-03-01

End Date2027-02-28

Agency Details

Awarding AgencyDepartment of Veterans Affairs

Awarding Sub AgencyDepartment of Veterans Affairs

Awarding Office250-NETWORK CONTRACT OFFICE 10 (36C250)

Funding AgencyDepartment of Veterans Affairs

Funding Sub AgencyDepartment of Veterans Affairs

Funding Office541-BRECKSVILLE (00541)

Recipient Details

RecipientPROGENICS PHARMACEUTICALS INC

Recipient Location331 TREBLE COVE ROAD NORTH BILLERICA MASSACHUSETTS, UNITED STATES

Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions

Transaction #0 | $1,181,225.28February 28, 2026

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $1,181,225.28 to PROGENICS PHARMACEUTICALS INC. The payment included a Subsidy Cost of $0.00.